Documentos relacionados

1. Altered HLA-A2-restricted TP53 epitope induces specific CTL cytotoxicity against hepatocellular carcinoma.
2. Orthopoxvirus-Specific T-Cell Responses in Convalescent Mpox Patients.
3. Detection of Low-Frequency Epitope-Specific T Cells in Blood of Healthy Individuals according to an Optimized In Vitro Amplification System.
4. <i>In silico</i> and <i>in vitro</i> arboviral MHC class I-restricted-epitope signatures reveal immunodominance and poor overlapping patterns.
5. An altered HLA-A0201-restricted MUC1 epitope that could induce more efficient anti-tumor effects against gastric cancer.
6. Cryptic MHC-E epitope from influenza elicits a potent cytolytic T cell response.
7. Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies.
8. Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity.
9. DNA prime-protein boost vaccine encoding HLA-A2, HLA-A24 and HLA-DR1 restricted epitopes of CaNA2 against visceral leishmaniasis.
10. Antibodies from primary humoral responses modulate the recruitment of naive B cells during secondary responses.